Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma

Chapman, BC; Gleisner, A; Rigg, D; Messersmith, W; Paniccia, A; Meguid, C; Gajdos, C; McCarter, MD; Schulick, RD; Edil, BH

Edil, BH (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Surg, John A Schilling Chair Surg, Andrews Acad Tower 9000,800 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.

JOURNAL OF THE PANCREAS, 2018; 19 (2): 75

Abstract

Context Neoadjuvant chemotherapy is increasingly used in borderline resectable and locally advanced pancreatic cancer to facilitate surgical resection......

Full Text Link